Laddar...
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...
Sparad:
| I publikationen: | Oncoimmunology |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028326/ https://ncbi.nlm.nih.gov/pubmed/32117591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1726168 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|